ATP-induced photoreceptor death in a feline model of retinal degeneration

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 12, 2014, Pages 8319-8329

  Aplin, Felix P ^a,b   Luu, Chi D ^a   Vessey, Kirstan A ^a   Guymer, Robyn H ^a   Shepherd, Robert K ^a,b   Fletcher, Erica L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Bionics Institute   (Australia)

Author keywords

Animal model; ATP induced retinal degeneration; Feline; Photoreceptor; Retinitis pigmentosa

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAT; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FELINE MODEL; NICK END LABELING; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OSCILLATORY POTENTIAL; PHOTORECEPTOR; PIGMENT EPITHELIUM; RETINA CONE; RETINA DEGENERATION; RETINA ROD; RETINAL THICKNESS; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; INTRAVITREAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TOXICITY;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CATS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; INTRAVITREAL INJECTIONS; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL DEGENERATION; RETINAL ROD PHOTORECEPTOR CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84919326997     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-15732     Document Type: Article

References (71)

1. Taylor HR, Keeffe JE, Vu HTV, et al. Vision loss in Australia. Med J Aust. 2005; 182: 565-568.
2. Fariss RN, Li ZY, Milam AH. Abnormalities in rod photoreceptors, amacrine cells, and horizontal cells in human retinas with retinitis pigmentosa. Am J Ophthalmol. 2000; 129: 215-223.
3. Jones BW, Watt CB, Frederick JM, et al. Retinal remodeling triggered by photoreceptor degenerations. J Comp Neurol. 2003; 464: 1-16.
4. Kalloniatis M, Fletcher EL. Retinitis pigmentosa: understanding the clinical presentation, mechanisms and treatment options. Clin Exp Optom. 2004; 87: 65-80.
5. Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res. 2003; 22: 607-655.
6. Strettoi E, Pignatelli V, Rossi C, Porciatti V, Falsini B. Remodeling of second-order neurons in the retina of rd/rd mutant mice. Vision Res. 2003; 43: 867-877.
7. O'Brien EE, Greferath U, Vessey KA, Jobling AI, Fletcher EL. Electronic restoration of vision in those with photoreceptor degenerations. Clin Exp Optom. 2012; 95: 473-483.
8. Seiler MJ, Aramant RB. Cell replacement and visual restoration by retinal sheet transplants. Prog Retin Eye Res. 2012; 31: 661-687.
9. Dahlmann-Noor A, Vijay S, Jayaram H, Limb A, Khaw PT. Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve. Can J Ophthalmol. 2010; 45: 333-341.
10. Singh MS, Issa PC, Butler R, et al. Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. Proc Natl Acad Sci U S A. 2013; 110: 1101-1106.
11. Bertschinger DR, Beknazar E, Simonutti M, et al. A review of in vivo animal studies in retinal prosthesis research. Graefes Arch Clin Exp Ophthalmol. 2008; 246: 1505-1517.
12. Nayagam DAX, Williams RA, Allen PJ, et al. Chronic electrical stimulation with a suprachoroidal retinal prosthesis: a preclinical safety and efficacy study. PLoS One. 2014; 9: e97182.
13. Narfstrom K. Progressive retinal atrophy in the Abyssinian cat. Clinical characteristics. Invest Ophthalmol Vis Sci. 1985; 26: 193-200.
14. Narfstrom K, Nilsson SE. Progressive retinal atrophy in the Abyssinian cat. Electron microscopy. Invest Ophthalmol Vis Sci. 1986; 27: 1569-1576.
15. Wrigstad A, Nilsson SEG, Narfstrom K. Ultrastructural changes of the retina and the retinal pigment epithelium in Briard dogs with hereditary congenital night blindness and partial day blindness. Exp Eye Res. 1992; 55: 805-818.
16. Narfstrom K, Wrigstad A, Nilsson SEG. The Briard dog: a new animal model of congenital stationary night blindness. Br J Ophthalmol. 1989; 73: 750-756.
17. Sargan DR, Clements PJ, Sohal A, Gregory CY, Bhattacharya SS, Petersen-Jones SM. Progressive retinal atrophy: a model for retinitis pigmentosa in companion animals. Gene Ther. 1994; 1(suppl 1): S89.
18. Yokoyama D, MacHida S, Kondo M, Terasaki H, Nishimura T, Kurosaka D. Pharmacological dissection of multifocal electroretinograms of rabbits with Pro347Leu rhodopsin mutation. Jpn J Ophthalmol. 2010; 54: 458-466.
19. Li ZY, Wong F, Chang JH, et al. Rhodopsin transgenic pigs as a model for human retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1998; 39: 808-819.
20. Jones BW, Kondo M, Terasaki H, et al. Retinal remodeling in the Tg P347L rabbit, a large-eye model of retinal degeneration. J Comp Neurol. 2011; 519: 2713-2733.
21. Kiuchi K, Yoshizawa K, Shikata N, Moriguchi K, Tsubura A. Morphologic characteristics of retinal degeneration induced by sodium iodate in mice. Curr Eye Res. 2002; 25: 373-379.
22. Tsubura A, Lai YC, Miki H, et al. Review: animal models of Nmethyl-N-nitrosourea-induced mammary cancer and retinal degeneration with special emphasis on therapeutic trials. In Vivo. 2011; 25: 11-22.
23. Puthussery T, Fletcher E. Extracellular ATP induces retinal photoreceptor apoptosis through activation of purinoceptors in rodents. J Comp Neurol. 2009; 513: 430-440.
24. Vessey KA, Greferath U, Aplin FP, et al. Adenosine triphosphate-induced photoreceptor death and retinal remodeling in rats. J Comp Neurol. 2014; 522: 2928-2950.
25. Köles L, Leichsenring A, Rubini P, Illes P. P2 receptor signaling in neurons and glial cells of the central nervous system. Adv Pharmacol. 2011; 61: 441-493.
26. Wang X, Arcuino G, Takano T, et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med. 2004; 10: 821-827.
27. Peng W, Cotrina ML, Han X, et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci U S A. 2009; 106: 12489-12493.
28. Fletcher EL. Mechanisms of photoreceptor death during retinal degeneration. Optom Vis Sci. 2010; 87: 269-275.
29. Puthussery T, Fletcher EL. Synaptic localization of P2X7 receptors in the rat retina. J Comp Neurol. 2004; 472: 13-23.
30. Puthussery T, Fletcher EL. P2X2 receptors on ganglion and amacrine cells in cone pathways of the rat retina. J Comp Neurol. 2006; 496: 595-609.
31. Hu H, Lu W, Zhang M, et al. Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo. Exp Eye Res. 2010; 91: 425-432.
32. Zhang X, Zhang M, Laties AM, Mitchell CH. Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation. J Neurochem. 2006; 98: 566-575.
33. Zhang X, Zhang M, Laties AM, Mitchell CH. Stimulation of P2X7 receptors elevates Ca2þ and kills retinal ganglion cells. Invest Ophthalmol Vis Sci. 2005; 46: 2183-2191.
34. Vakkur GJ, Bishop PO. The schematic eye in the cat. Vision Res. 1963; 3: 357-381.
35. Notomi S, Hisatomi T, Murakami Y, et al. Dynamic increase in extracellular ATP accelerates photoreceptor cell apoptosis via ligation of P2RX7 in subretinal hemorrhage. PLoS One. 2013; 8: e53338.
36. Gekeler F, Szurman P, Grisanti S, et al. Compound subretinal prostheses with extra-ocular parts designed for human trials: successful long-term implantation in pigs. Graefes Arch Clin Exp Ophthalmol. 2007; 245: 230-241.
37. Güven D, Weiland JD, Fujii G, et al. Long-term stimulation by active epiretinal implants in normal and RCD1 dogs. J Neural Eng. 2005; 2: S65-S73.
38. Terasawa Y, Tashiro H, Nakano Y, Osawa K, Ozawa M. Safety assessment of semichronic suprachoroidal electrical stimulation to rabbit retina. Conf Proc IEEE Eng Med Biol Soc. 2013; 2013: 3567-3570.
39. Villalobos J, Nayagam DA, Allen PJ, et al. A wide-field suprachoroidal retinal prosthesis is stable and well tolerated following chronic implantation. Invest Ophthalmol Vis Sci. 2013; 54: 3751-3762.
40. Weymouth AE, Vingrys AJ. Rodent electroretinography: methods for extraction and interpretation of rod and cone responses. Prog Retin Eye Res. 2008; 27: 1-44.
41. Jobling AI, Vessey KA, Waugh M, Mills SA, Fletcher EL. A naturally occurring mouse model of achromatopsia: characterization of the mutation in cone transducin and subsequent retinal phenotype. Invest Ophthalmol Vis Sci. 2013; 54: 3350-3359.
42. Komaromy AM, Smith PJ, Brooks DE. Electroretinography in dogs and cats. Part I. Retinal morphology and physiology. Compend Contin Educ Vet. 1998; 20: 343-350.
43. Bush RA, Sieving PA. A proximal retinal component in the primate photopic ERG a-wave. Invest Ophthalmol Vis Sci. 1994; 35: 635-645.
44. Robson JG, Frishman LJ. Dissecting the dark-adapted electroretinogram. Doc Ophthalmol. 1998; 95: 187-215.
45. Robson JG, Saszik SM, Ahmed J, Frishman LJ. Rod and cone contributions to the a-wave of the electroretinogram of the macaque. J Physiol. 2003; 547: 509-530.
46. Vaegan, Millar TJ. Effect of kainic acid and NMDA on the pattern electroretinogram, the scotopic threshold response, the oscillatory potentials and the electroretinogram in the urethane anaesthetized cat. Vision Res. 1994; 34: 1111-1125.
47. Ikenoya K, Kondo M, Piao C-H, Kachi S, Miyake Y, Terasaki H. Preservation of macular oscillatory potentials in eyes of patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2007; 48: 3312-3317.
48. Puthussery T, Yee P, Vingrys AJ, Fletcher EL. Evidence for the involvement of purinergic P2X7 receptors in outer retinal processing. Eur J Neurosci. 2006; 24: 7-19.
49. Ward MM, Puthussery T, Vessey KA, Fletcher EL. The role of purinergic receptors in retinal function and disease. Adv Exp Med Biol. 2010; 664: 385-391.
50. Mitchell CH. Release of ATP by a human retinal pigment epithelial cell line: potential for autocrine stimulation through subretinal space. J Physiol. 2001; 534: 193-202.
51. Mitchell CH, Reigada D. Purinergic signalling in the subretinal space: a role in the communication between the retina and the RPE. Purinergic Signal. 2008; 4: 101-107.
52. Ricatti MJ, Alfie LD, Lavoie ÉG, Sévigny J, Schwarzbaum PJ, Faillace MP. Immunocytochemical localization of NTPDases1 and 2 in the neural retina of mouse and zebrafish. Synapse. 2009; 63: 291-307.
53. García-Ayuso D, Ortín-Martínez A, Jiménez-López M, et al. Changes in the photoreceptor mosaic of P23H-1 rats during retinal degeneration: implications for rod-cone dependent survival. Invest Ophthalmol Vis Sci. 2013; 54: 5888-5900.
54. Bovolenta P, Cisneros E. Retinitis pigmentosa: cone photoreceptors starving to death. Nat Neurosci. 2009; 12: 5-6.
55. Fasiuddin A. Inherited retinal degenerations. Int Ophthalmol Clin. 2010; 50: 45-56.
56. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998; 17: 175-205.
57. Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A. 2008; 105: 15112-15117.
58. Speros P, Price J. Oscillatory potentials. History, techniques and potential use in the evaluation of disturbances of retinal circulation. Surv Ophthalmol. 1981; 25: 237-252.
59. Kim IT, Ha SM, Yoon KC. Electroretinographic studies in rhegmatogenous retinal detachment before and after reattachment surgery. Kor J Ophthalmol. 2001; 15: 118-127.
60. Gong Y, Wu X, Sun X, Zhang X, Zhu P. Electroretinogram changes after scleral buckling surgery of retinal detachment. Doc Ophthalmol. 2008; 117: 103-109.
61. Lewis GP, Charteris DG, Sethi CS, Fisher SK. Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery. Eye. 2002; 16: 375-387.
62. Aleman TS, Cideciyan AV, Sumaroka A, et al. Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations. Invest Ophthalmol Vis Sci. 2008; 49: 1580-1591.
63. Zhang Y, Huang H, Wei S, et al. Characterization of retinal nerve fiber layer thickness changes associated with Leber's hereditary optic neuropathy by optical coherence tomography. Exp Ther Med. 2014; 7: 483-487.
64. Hood DC, Lazow MA, Locke KG, Greenstein VC, Birch DG. The transition zone between healthy and diseased retina in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2011; 52: 101-108.
65. Steinberg RH, Reid M, Lacy PL. The distribution of rods and cones in the retina of the cat (Felis domesticus). J Comp Neurol. 1973; 148: 229-248.
66. Jones BW, Watt CB, Marc RE. Retinal remodelling. Clin Exp Optom. 2005; 88: 282-291.
67. Marc RE, Jones BW, Watt CB, Vazquez-Chona F, Vaughan DK, Organisciak DT. Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis. 2008; 14: 782-806.
68. Fletcher EL, Jobling AI, Vessey KA, Luu C, Guymer RH, Baird PN. Animal models of retinal disease. Prog Mol Biol Transl Sci. 2011; 100: 211-286.
69. Kang Derwent JJ, Padnick-Silver L, McRipley M, Giuliano E, Linsenmeier RA, Narfström K. The electroretinogram components in Abyssinian cats with hereditary retinal degeneration. Invest Ophthalmol Vis Sci. 2006; 47: 3673-3682.
70. Rah H, Maggs DJ, Blankenship TN, Narfstrom K, Lyons LA. Early-onset, autosomal recessive, progressive retinal atrophy in Persian cats. Invest Ophthalmol Vis Sci. 2005; 46: 1742-1747.
71. Pennesi ME, Michaels KV, Magee SS, et al. Long-term characterization of retinal degeneration in rd1 and rd10 mice using spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012; 53: 4644-4656.